| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |